Its platform technology approach is unique in that there are three things that it utilizes to create the best-in-class TL1A drug, as follows: De novo antibody creation - Creating a targeting of ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The Centers for Disease Control and Prevention (CDC) issued a public health warning about prescription medications sold ...
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...
Sunovion hopes the twice-daily drug will become the first nebulised long-acting muscarinic antagonist for COPD, based on phase 3 data. But the company has competition from Theravance and Mylan.
And the only record of the drugs was a notation on the autopsy report, Curtice told Yakima police detectives. But the head of the state coroner’s association said that is not a best practice for ...